Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 879419, 8 pages
http://dx.doi.org/10.1155/2012/879419
Research Article

Simulating Sleep Apnea by Exposure to Intermittent Hypoxia Induces Inflammation in the Lung and Liver

1Ciências Médicas, Programa de Pós-Graduação em Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), 90035-903 Porto Alegre, RS, Brazil
2Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul, 90035-903 Porto Alegre, RS, Brazil
3Faculdade Cenecista de Bento Gonçalves, 95700-973 Bento Gonçalves, RS, Brazil
4Programa de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), 90035-903 Porto Alegre, RS, Brazil
5Universidade Luterana do Brasil, 92425-900 Canoas, RS, Brazil

Received 22 September 2012; Revised 15 October 2012; Accepted 28 October 2012

Academic Editor: Fábio Santos Lira

Copyright © 2012 Darlan Pase da Rosa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Dempsey, S. C. Veasey, B. J. Morgan, and C. P. O'Donnell, “Pathophysiology of sleep apnea,” Physiological Reviews, vol. 90, no. 1, pp. 47–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Lavie, “Obstructive sleep apnoea syndrome—an oxidative stress disorder,” Sleep Medicine Reviews, vol. 7, no. 1, pp. 35–51, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Lavie, “Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach,” Neurologic Clinics, vol. 23, no. 4, pp. 1059–1075, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. J. Suzuki, V. Jain, A. M. Park, and R. M. Day, “Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases,” Free Radical Biology and Medicine, vol. 40, no. 10, pp. 1683–1692, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Lavie, “Oxidative stress-A unifying paradigm in obstructive sleep apnea and comorbidities,” Progress in Cardiovascular Diseases, vol. 51, no. 4, pp. 303–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. K. Aalto and K. O. Raivio, “Nucleotide depletion due to reactive oxygen metabolites in endothelial cells: effects of antioxidants and 3-aminobenzamide,” Pediatric Research, vol. 34, no. 5, pp. 572–576, 1993. View at Google Scholar · View at Scopus
  7. C. Szabó, B. Zingarelli, and A. L. Salzman, “Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite,” Circulation Research, vol. 78, no. 6, pp. 1051–1063, 1996. View at Google Scholar · View at Scopus
  8. J. Zhang, V. L. Dawson, T. M. Dawson, and S. H. Snyder, “Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity,” Science, vol. 263, no. 5147, pp. 687–689, 1994. View at Google Scholar · View at Scopus
  9. H. Singh, R. Pollock, J. Uhanova, M. Kryger, K. Hawkins, and G. Y. Minuk, “Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease,” Digestive Diseases and Sciences, vol. 50, no. 12, pp. 2338–2343, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Tanné, F. Gagnadoux, O. Chazouillères et al., “Chronic liver injury during obstructive sleep apnea,” Hepatology, vol. 41, no. 6, pp. 1290–1296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Tatsumi and T. Saibara, “Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis,” Hepatology Research, vol. 33, no. 2, pp. 100–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Jouët, J. M. Sabaté, D. Maillard et al., “Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study,” Obesity Surgery, vol. 17, no. 4, pp. 478–485, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. E. R. Kallwitz, J. Herdegen, J. Madura, S. Jakate, and S. J. Cotler, “Liver enzymes and histology in obese patients with obstructive sleep apnea,” Journal of Clinical Gastroenterology, vol. 41, no. 10, pp. 918–921, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Zamora-Valdés and N. Méndez-Sánchez, “Experimental evidence of obstructive sleep apnea syndrome as a second hit accomplice in nonalcoholic steatohepatitis pathogenesis,” Annals of Hepatology, vol. 6, no. 4, pp. 281–283, 2007. View at Google Scholar · View at Scopus
  15. L. Kheirandish-Gozal, O. Sans Capdevila, E. Kheirandish, and D. Gozal, “Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea,” Chest, vol. 133, no. 1, pp. 92–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Norman, W. A. Bardwell, F. Arosemena et al., “Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea,” Sleep, vol. 31, no. 1, pp. 121–126, 2008. View at Google Scholar · View at Scopus
  17. V. Savransky, A. Nanayakkara, A. Vivero et al., “Chronic intermittent hypoxia predisposes to liver injury,” Hepatology, vol. 45, no. 4, pp. 1007–1013, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Savransky, C. Reinke, J. Jun et al., “Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice: experimental physiology—research paper,” Experimental Physiology, vol. 94, no. 2, pp. 228–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ryan, C. T. Taylor, and W. T. McNicholas, “Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?” Thorax, vol. 64, no. 7, pp. 631–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. K. Htoo, H. Greenberg, S. Tongia et al., “Activation of nuclear factor κB in obstructive sleep apnea: a pathway leading to systemic inflammation,” Sleep and Breathing, vol. 10, no. 1, pp. 43–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Greenberg, X. Ye, D. Wilson, A. K. Htoo, T. Hendersen, and S. F. Liu, “Chronic intermittent hypoxia activates nuclear factor-κB in cardiovascular tissues in vivo,” Biochemical and Biophysical Research Communications, vol. 343, no. 2, pp. 591–596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Selmi, N. Montano, R. Furlan, C. L. Keen, and M. E. Gershwin, “Inflammation and oxidative stress in obstructive sleep apnea syndrome,” Experimental Biology and Medicine, vol. 232, no. 11, pp. 1409–1413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Yamauchi, S. Tamaki, K. Tomoda et al., “Evidence for activation of nuclear factor kappaB in obstructive sleep apnea,” Sleep and Breathing, vol. 10, no. 4, pp. 189–193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Carmeliet, Y. Dor, J. M. Herbert et al., “Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis,” Nature, vol. 395, no. 6701, pp. 485–490, 1998. View at Google Scholar · View at Scopus
  25. D. Martinez, C. Z. Fiori, D. Baronio et al., “Brown adipose tissue: is it affected by intermittent hypoxia?” Lipids in Health and Disease, vol. 9, article no. 121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. [Anon], “AVMA updates its euthanasia guidelines,” Veterinary Record, vol. 161, no. 15, pp. 502–502, 2007. View at Google Scholar
  27. [Anon], “AVMA releases updated euthanasia guidelines,” Journal of the American Veterinary Medical Association, vol. 231, no. 6, pp. 827–827, 2007. View at Google Scholar
  28. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  29. J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology, vol. 52, pp. 302–310, 1978. View at Publisher · View at Google Scholar · View at Scopus
  30. H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase,” Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at Google Scholar · View at Scopus
  31. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  32. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Towbin, T. Staehelin, and J. Gordon, “Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 9, pp. 4350–4354, 1979. View at Google Scholar · View at Scopus
  34. I. Shpirer, L. Copel, E. Broide, and A. Elizur, “Continuous positive airway pressure improves sleep apnea associated fatty liver,” Lung, vol. 188, no. 4, pp. 301–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two “Hits”?” Gastroenterology, vol. 114, no. 4, pp. 842–845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Seki, T. Kitada, and H. Sakaguchi, “Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases,” Hepatology Research, vol. 33, no. 2, pp. 132–134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. J. George, N. Pera, N. Phung, I. Leclercq, J. Y. Hou, and G. Farrell, “Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis,” Journal of Hepatology, vol. 39, no. 5, pp. 756–764, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. D. P. Rosa, D. Martinez, J. N. Picada, J. G. Semedo, and N. P. Marroni, “Hepatic oxidative stress in an animal model of sleep apnoea: effects of different duration of exposure,” Comparative Hepatology, vol. 10, article 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Park and Y. J. Suzuki, “Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice,” Journal of Applied Physiology, vol. 102, no. 5, pp. 1806–1814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Dutta, K. Ray, V. K. Singh, P. Vats, S. N. Singh, and S. B. Singh, “L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats,” Experimental Physiology, vol. 93, no. 10, pp. 1139–1146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Bertuglia and R. J. Reiter, “Melatonin reduces microvascular damage and insulin resistance in hamsters due to chronic intermittent hypoxia,” Journal of Pineal Research, vol. 46, no. 3, pp. 307–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Lavie, A. Hefetz, R. Luboshitzky, and P. Lavie, “Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment,” Journal of Molecular Neuroscience, vol. 21, no. 1, pp. 57–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Y. Sohn, F. Krotz, T. Gloe et al., “Differential regulation of xanthine and NAD(P)H oxidase by hypoxia in human umbilical vein endothelial cells. Role of nitric oxide and adenosine,” Cardiovascular Research, vol. 58, no. 3, pp. 638–646, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Cairo, E. Castrusini, G. Minotti, and A. Bernelli-Zazzera, “Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury,” The FASEB Journal, vol. 10, no. 11, pp. 1326–1335, 1996. View at Google Scholar · View at Scopus
  45. W. Jordan, S. Cohrs, D. Degner et al., “Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome,” Journal of Neural Transmission, vol. 113, no. 2, pp. 239–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. S. A. Phillips, E. B. Olson, J. H. Lombard, and B. J. Morgan, “Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries,” Journal of Applied Physiology, vol. 100, no. 4, pp. 1117–1123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. D. R. Mole, C. Blancher, R. R. Copley et al., “Genome-wide association of hypoxia-inducible factor (HIF)-1α and HIF-2α DNA binding with expression profiling of hypoxia-inducible transcripts,” Journal of Biological Chemistry, vol. 284, no. 25, pp. 16767–16775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. G. L. Semenza, “Regulation of oxygen homeostasis by hypoxia-Inducible factor 1,” Physiology, vol. 24, no. 2, pp. 97–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Yuan, S. A. Khan, W. Luo et al., “Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia,” Journal of Cellular Physiology, vol. 226, no. 11, pp. 2925–2933, 2011. View at Google Scholar
  50. B. Nath, I. Levin, T. Csak et al., “Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice,” Hepatology, vol. 53, no. 5, pp. 1526–1537, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. C. C. Blouin, E. L. Pagé, G. M. Soucy, and D. E. Richard, “Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1α,” Blood, vol. 103, no. 3, pp. 1124–1130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Peyssonnaux, P. Cejudo-Martin, A. Doedens, A. S. Zinkernagel, R. S. Johnson, and V. Nizet, “Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis,” Journal of Immunology, vol. 178, no. 12, pp. 7516–7519, 2007. View at Google Scholar · View at Scopus
  53. W. Moritz, F. Meier, D. M. Stroka et al., “Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression,” The FASEB Journal, vol. 16, no. 7, pp. 745–747, 2002. View at Google Scholar · View at Scopus
  54. N. Akakura, M. Kobayashi, I. Horiuchi et al., “Constitutive expression of hypoxia-inducible factor-lα renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation,” Cancer Research, vol. 61, no. 17, pp. 6548–6554, 2001. View at Google Scholar · View at Scopus
  55. P. van Uden, N. S. Kenneth, and S. Rocha, “Regulation of hypoxia-inducible factor-1αa by NF-κB,” Biochemical Journal, vol. 412, no. 3, pp. 477–484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Rius, M. Guma, C. Schachtrup et al., “NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α,” Nature, vol. 453, no. 7196, pp. 807–811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Beraza, Y. Malato, S. Vander Borght et al., “Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis,” Gut, vol. 57, no. 5, pp. 655–663, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. H. L. Pahl, “Activators and target genes of Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6853–6866, 1999. View at Google Scholar · View at Scopus
  59. N. Ferrara, “Vascular endothelial growth factor: basic science and clinical progress,” Endocrine Reviews, vol. 25, no. 4, pp. 581–611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. E. Minet, G. Michel, J. Remacle, and C. Michiels, “Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis,” International Journal of Molecular Medicine, vol. 5, no. 3, pp. 253–259, 2000. View at Google Scholar · View at Scopus
  61. A. E. Greijer and E. Van Der Wall, “The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis,” Journal of Clinical Pathology, vol. 57, no. 10, pp. 1009–1014, 2004. View at Publisher · View at Google Scholar · View at Scopus